Article | October 18, 2024

Consumer Products Company Reckitt Investing $145M In Wilson Pharma Manufacturing Site

manufacturing-tablets-GettyImages-1283489812

Reckitt Benckiser, a multinational consumer goods company based in the UK and the Netherlands, is making a $145.59 million investment to establish a pharmaceutical manufacturing facility in Wilson, North Carolina. This new plant will focus on producing Mucinex, an over-the-counter medication. Governor Roy Cooper announced that this project could revitalize the facility, which has been winding down operations under its previous owner, and could create up to 289 jobs. Read on to learn more about this major life sciences investment.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

North Carolina Biotechnology Center